Show all Events 22 Sep 2026 from 8:30 AM to 12:30 PM EDT Telix 2026 R&D Day 2026 (New York City) 15 Sep 2026 10:30 AM EDT H.C. Wainwright 28th Annual Global Investment Conference 14 Sep 2026 9:15 AM EDT Morgan Stanley 24th Annual Global Healthcare Conference 19 Aug 2026 7:00 PM EDT Telix H1 2026 Results Webcast 29 Jun 2026 5:00 PM EDT Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions All Events Presentations H1 2026 Results Presentation All Presentations News 09 Sep 2026 Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference 01 Sep 2026 Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway 02 Sep 2026 Telix Completes Enrollment in Phase 3 BiPASS Study 01 Sep 2026 Telix Appoints David Gill as Chair 19 Aug 2026 Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline All News Releases
29 Jun 2026 5:00 PM EDT Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions
09 Sep 2026 Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference
19 Aug 2026 Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline